✦ LIBER ✦

Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site

✍ Scribed by Wallez, Y; Cand, F; Cruzalegui, F; Wernstedt, C; Souchelnytskyi, S; Vilgrain, I; Huber, P

Book ID: 110071862
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 310 KB
Volume: 26
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1209855

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heterogeneity in the angiogenic response

Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: Assessment by voxel analysis of dynamic contrast-enhanced MRI

✍ Ka-Loh Li; Lisa J. Wilmes; Roland G. Henry; Maria G. Pallavicini; John W. Park; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB

## Abstract ## Purpose To investigate the heterogeneity in the angiogenic response of a human breast cancer xenograft to a novel vascular endothelial growth factor (VEGF)‐receptor tyrosine kinase inhibitor, AG‐013736, using dynamic contrast‐enhanced MR imaging (DCE‐MRI). ## Materials and Methods

Comparative efficacy of vascular endothe

Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI

✍ Kwonoh Park, Jae-Lyun Lee, Inkeun Park, Seongjoon Park, Yongcheol Ahn, Jin-Hee A 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 193 KB